eras-007
Showing 1 - 2 of 2
Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)
Withdrawn
- Acute Myeloid Leukemia
- ERAS-007
- +2 more
-
San Francisco, California
- +3 more
Jun 13, 2022
Advanced or Metastatic Solid Tumors Trial in United States (ERAS-007)
Recruiting
- Advanced or Metastatic Solid Tumors
- ERAS-007
-
Denver, Colorado
- +4 more
Jul 6, 2021